Bio Medica Laboratories Limited IPO

Established in August 2015, Bio Medica Laboratories specializes in manufacturing pharmaceutical parenteral formulations, producing an extensive range of ethical drugs, generic medications, and over-the-counter (OTC) products. The company's production capabilities focus on liquid and dry-powder injectables designed for a variety of therapeutic applications.

Don't have a Navia account? Sign up

These injectable formulations are manufactured in both single-dose and multi-dose formats, ensuring adaptability across clinical settings. Through this specialized production line, the company effectively serves the distinct medical needs of both human and veterinary healthcare sectors.

How do I apply for the Bio Medica Laboratories IPO?

You can apply for the Bio Medica Laboratories IPO using any supported UPI app by following two steps:

• Enter your bid on Navia App
• Accept UPI mandate on your phone

On acceptance of the mandate, the bid amount will get blocked in your bank account.